Evidence map›Paper›PMID 31924232›Full record

ArticleItalian journal of pediatrics2020

Epidemiology and drug allergy results in children investigated in allergy unit of a tertiary-care paediatric hospital setting.

A Piccorossi, G Liccioli, S Barni, L Sarti, M Giovannini, A Verrotti, E Novembre, F Mori

Open access · goldAbstract read
In one paragraph

Article in Italian journal of pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Clinical and behavioral determinants in pediatric non-immediate drug hypersensitivity: Low confirmation but persistent avoidance.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. When toothache results in asthma diagnosis.International journal of occupational medicine and environmental health · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Drug Allergy in children: focus on beta-lactams and NSAIDs.Acta bio-medica : Atenei Parmensis · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

A PiccorossiDepartment of Pediatrics, San Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
G LiccioliAllergy Unit, Anna Meyer Children's Hospital, Florence, Italy. giulialiccioli@gmail.com.ORCID http://orcid.org/0000-0002-5216-0423
S BarniAllergy Unit, Anna Meyer Children's Hospital, Florence, Italy.
L SartiAllergy Unit, Anna Meyer Children's Hospital, Florence, Italy.
M GiovanniniAllergy Unit, Anna Meyer Children's Hospital, Florence, Italy.
A VerrottiDepartment of Pediatrics, San Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
E NovembreAllergy Unit, Anna Meyer Children's Hospital, Florence, Italy.
F MoriAllergy Unit, Anna Meyer Children's Hospital, Florence, Italy.
Meyer Children's Hospital · ITUniversity of L'Aquila · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveDrug Hypersensitivity Reactions (DHRs) are considered adverse effects of medications that resemble allergy symptoms. The reported positive clinical history of pediatric drug reactions is about 10%, however, after allergy investigations, only a small percent is confirmed as hypersensitivity. The aim of this study was to analyze the clinical history, allergy work-up results and sensitization profile of children and adolescents referred to our Allergy Unit for suspected DHRs.

methodsThe study evaluated data related to a group of children with a positive history of drug reactions during a two-year period. The allergy work-up consisted of in vivo and in vitro tests, in accordance with the recommendations of the ENDA/EAACI guidelines.

resultsData from a group of 637 patients [348 M (54.6%); 289 F (45.4%)] were retrospectively analyzed. Beta lactams (BLs) were the most common drugs involved in the reported clinical history, followed by non-steroidal anti-inflammatory drugs (NSAIDs). Severe cutaneous adverse reactions (SCARs) were most frequently observed during BL treatment. The confirmation of BL hypersensitivity was higher for immediate reactions (IRs) [9.4%; 5.1% through positive skin tests (STs) and 5.5% through drug provocation test (DPT)] compared to non-immediate reactions (non-IRs) (8.1%; 2.2% through STs and 6.2% through DPT). A higher number of positive results was obtained for BLs and macrolides when the tests were performed within 12 months after the index reaction (p < 0.05). During DPTs with amoxicillin-clavulanic acid, four hypersensitivity reactions (including one anaphylaxis) occurred despite negative STs.

conclusionOur data demonstrated that only 9.1% of patients resulted in being positive to allergy tests which is in line with the data in literature. An allergy work-up is mandatory for excluding suspected hypersensitivity.

Indexed as

AdolescentChildChild, PreschoolDrug HypersensitivityFemaleHospitals, PediatricHumansImmunoglobulin EInfantItalyMaleRetrospective StudiesSkin TestsTertiary Health CareImmunoglobulin EAllergy testsDrug hypersensitivity reactionEpidemiologyPediatrics

Identifiers

PMID31924232
PMCPMC6954623
OpenAlexW3006376620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.